
TZS 3,000
In stock
: ORODAR IS A COMBINATION ANTIMALARIAL MEDICINE CONTAINING SULFADOXINE 500MG AND PYRIMETHAMINE 25MG PER TABLET. THE TWO ACTIVE INGREDIENTS WORK TOGETHER TO INHIBIT FOLATE SYNTHESIS IN MALARIA PARASITES, PREVENTING THEIR GROWTH AND MULTIPLICATION. IT IS PRIMARILY USED FOR INTERMITTENT PREVENTIVE TREATMENT OF MALARIA DURING PREGNANCY (IPTP-SP) IN ELIGIBLE PREGNANT WOMEN, ACCORDING TO NATIONAL MALARIA PREVENTION GUIDELINES. IT IS NOT RECOMMENDED AS ROUTINE FIRST-LINE TREATMENT FOR UNCOMPLICATED MALARIA DUE TO WIDESPREAD PARASITE RESISTANCE. IT SHOULD NOT BE USED IN PATIENTS WITH SULFONAMIDE ALLERGY OR TOGETHER WITH COTRIMOXAZOLE PROPHYLAXIS. USE DURING PREGNANCY SHOULD FOLLOW APPROVED ANTENATAL CARE GUIDELINES.
ORODAR IS A COMBINATION ANTIMALARIAL MEDICINE CONTAINING SULFADOXINE 500MG AND PYRIMETHAMINE 25MG PER TABLET. THE TWO ACTIVE INGREDIENTS WORK TOGETHER TO INHIBIT FOLATE SYNTHESIS IN MALARIA PARASITES, PREVENTING THEIR GROWTH AND MULTIPLICATION. IT IS PRIMARILY USED FOR INTERMITTENT PREVENTIVE TREATMENT OF MALARIA DURING PREGNANCY (IPTP-SP) IN ELIGIBLE PREGNANT WOMEN, ACCORDING TO NATIONAL MALARIA PREVENTION GUIDELINES. IT IS NOT RECOMMENDED AS ROUTINE FIRST-LINE TREATMENT FOR UNCOMPLICATED MALARIA DUE TO WIDESPREAD PARASITE RESISTANCE. IT SHOULD NOT BE USED IN PATIENTS WITH SULFONAMIDE ALLERGY OR TOGETHER WITH COTRIMOXAZOLE PROPHYLAXIS. USE DURING PREGNANCY SHOULD FOLLOW APPROVED ANTENATAL CARE GUIDELINES.